From time to time I receive emails asking me my opinion about the use of Etancercept by Dr. Edward Tobinick for the treatment of Alzheimer’s disease….. By Bob DeMarco Alzheimer’s Reading Room It seems like once every year the use of Etanercept for the treatment of Alzheimer’s disease pops up on the radar screen. This time around it might be meaningful. Last month, I received an email from Clinical Trials.gov alerting me to a new Phase II clinical trial for Etanercept. Safety and Tolerability of Etanercept in Alzheimer’s Disease So far, this study is not yet open for participant recruitment. It appears the drug trial will be limited to one location, the Memory Assessment and Research Centre, Moorgreen Hospital Southampton, Hampshire, United Kingdom. The fact that Wyeth is one of the collaborators did get my attention. From time to time I receive emails asking me my opinion about the use of Etancercept by Dr. Edward Tobinick for the treatment of Alzheimer’s disease. I would not allow my mother to receive this treatment. The treatment is expenisve, and there is no legitimate science to back up the claims being made by Dr. Tobinick. It is my belief, however, that each family should make their own decision about Etanercept. I am not a doctor or a scientist. I am an Alzheimer’s caregiver. We would be interested in participating in a Phase III clinical trial of Etanercept should it become available in a nearby location. I covered this issue pretty thoroughly in the past

Original Source of Etanercept as a Treatment for Alzheimer’s Disease — For Real This Time?